Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report) – Equities research analysts at Leede Financial issued their FY2027 earnings per share estimates for shares of Quipt Home Medical in a research note issued on Tuesday, February 11th. Leede Financial analyst D. Loe anticipates that the company will post earnings of ($0.10) per share for the year. The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.05) per share.
Quipt Home Medical (NASDAQ:QIPT – Get Free Report) last posted its earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.
Quipt Home Medical Stock Up 3.4 %
Insider Buying and Selling at Quipt Home Medical
In related news, VP Patrick Dennis Gamble bought 17,000 shares of the business’s stock in a transaction on Thursday, December 26th. The shares were purchased at an average cost of $2.45 per share, with a total value of $41,650.00. Following the acquisition, the vice president now owns 40,057 shares of the company’s stock, valued at $98,139.65. This represents a 73.73 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 13.40% of the company’s stock.
Hedge Funds Weigh In On Quipt Home Medical
A number of hedge funds have recently made changes to their positions in QIPT. Geode Capital Management LLC boosted its holdings in Quipt Home Medical by 0.8% in the fourth quarter. Geode Capital Management LLC now owns 512,304 shares of the company’s stock valued at $1,563,000 after acquiring an additional 4,242 shares during the last quarter. Wells Fargo & Company MN lifted its position in shares of Quipt Home Medical by 30.9% in the 4th quarter. Wells Fargo & Company MN now owns 23,851 shares of the company’s stock worth $73,000 after purchasing an additional 5,625 shares during the period. State Street Corp boosted its stake in shares of Quipt Home Medical by 1.0% in the 3rd quarter. State Street Corp now owns 621,388 shares of the company’s stock valued at $1,814,000 after purchasing an additional 6,317 shares during the last quarter. Barclays PLC increased its position in shares of Quipt Home Medical by 9.7% during the fourth quarter. Barclays PLC now owns 95,916 shares of the company’s stock worth $293,000 after buying an additional 8,491 shares during the period. Finally, Jane Street Group LLC raised its stake in Quipt Home Medical by 28.5% during the third quarter. Jane Street Group LLC now owns 41,926 shares of the company’s stock worth $122,000 after buying an additional 9,290 shares during the last quarter. 42.85% of the stock is currently owned by institutional investors.
Quipt Home Medical Company Profile
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Further Reading
- Five stocks we like better than Quipt Home Medical
- What Are Trending Stocks? Trending Stocks Explained
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- What is the Nikkei 225 index?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.